Specialty Pharmacy Times

October 2020
Volume: 3
Issue: 3

June 2020
Volume: 3
Issue: 2

February 2020
Volume: 3
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
4
Notable Updates in Medication Therapy Management in 2025
5
